New call-to-action
New call-to-action
New call-to-action

2024 FPWR PWS/SYS Research Symposium Retrospective

Another record-setting year for the most important event in PWS/SYS research!

In September, we were honored to host our annual meeting of researchers, physicians, and pharmaceutical companies interested in Prader-Willi or Schaaf-Yang syndromes. This event is consistently invigorating as the leaders in PWS/SYS research not only share their latest results and plans with their peers but also openly discuss challenges and begin to craft collaborative solutions.

Res SymposiumThis year we welcomed 132 researchers from around the globe and directly supported the travel of 17 trainees from 15 institutions in 5 countries with our Travel Award program. We were able to provide the opportunity for 60 presentations (the most ever!): 20 in poster form and 40 oral presentations. Of the oral presentations, 17 included clinical studies, while the remainder focused on underlying biological processes.

This year we noted an eruption of research in several exciting areas: brain imaging in patients, caregiver stress and coping, genetic therapies, interactions and activities of the PWS gene Snord116, newborn screening, and the 3D structure of chromosome 15.

Researchers also presented progress in the development and characterization of new organoids (brain-like models grown from single cells) and animal models of PWS and SYS and their use in preclinical drug testing. Of course, updates on the multiple clinical trials in progress and recently completed are always among the most inspiring presentations.

Abstracts of all presentations have been assembled into a booklet available for download here:

Download the 2024 Research Symposium Abstract Booklet

Our annal symposium also provides an opportunity for in-person meetings of several affinity groups that typically meet online: the PWS Clinical Investigation Collaborative (PWS-CLIC) comprised of clinicians from 30 sites in the US and Canada who discuss ways to improve the quality of research and care for people with PWS; the PWS Clinical Trials Consortium (PWS-CTC) uniting researchers, patients, and pharma companies to address unmet scientific, technical, clinical, and regulatory needs for PWS clinical trials; and the MAGEL2 Roundtable of researchers deeply interested in characterizing that specific protein’s function in molecular, cell, or animal models of PWS and SYS.  

Next year, in lieu of the regular symposium, we will be joining forces with IPWSO and PWSA|USA to host “United in Hope—an International PWS Conference." We hope to see you there!

take action for pws research

Topics: Research, Learning

Susan Hedstrom

author-image

Susan Hedstrom is the Executive Director for the Foundation for Prader-Willi Research. Passionate about finding treatments for PWS, Susan joined FPWR in 2009 shortly after her son, Jayden, was diagnosed with Prader-Willi Syndrome. Rather than accepting PWS as it has been defined, Susan has chosen to work with a team of pro-active and tireless individuals to accelerate PWS research in order to change the future of PWS. Inspired by her first FPWR conference and the team of researchers that were working to find answers for the syndrome, she joined the FPWR team in 2010 and led the development of the One SMALL Step walk program. Under Susan’s leadership, over $15 million has been raised for PWS related research.